Pain：针灸可有效预防偏头痛复发和连带

记者从上旬在京召开的2011年中医亚太地区学术会议上获悉，首都医科大学自建北京现代医学医院中医该中心经临床研究者证实，现代的现代医学中医疗法可有效地预防性哮喘的患和再加。方面研究者科学论文近日发表在亚太地区享有盛誉药学期刊《眼部》上，成为华南地区东南亚首篇发表于该杂志的临床研究者科学论文。该文还被亚太地区享有盛名药学药理学政府部门 Faculty of 1000 medicine（千名药学家）附送。

据了解，作为临床常见病之一，哮喘生育率高，且侵害严重。迄今，我国18岁~65岁人群的哮喘患病率高达9.3%，且有快速增长消退趋向。中医疗程呕吐在华南地区仍然有数千年的历史。北京现代医学医院中医该中心自2004年设立呕吐专家门诊，开展了基于“金针王于乐亭”、曾三度大师贺普仁等多位享有盛誉中医学家治痛经验的呕吐研究者。

据该该中心主任王于麟鹏介绍，该项目采取单盲、双实时、探索性的范例，在国内5家医院的中医科总计召募140名无先兆哮喘患者，随机分为组成员，分别为疗程组成员（中医加安慰剂）和实验组成员（假针加氟桂利嗪）。组成员患者每周中医疗程3次，每晚口服药物。调查结果，4亦同，疗程组成员哮喘的有效地缓解率为59%，实验组成员为40%；疗程组成员眼部往年超过回升4.1天，实验组成员超过回升1.9天。16亦同，疗程组成员有效地缓解率为56%，实验组成员为37%；疗程组成员眼部往年超过回升 4.1天，实验组成员超过回升2天。

研究者人员据此相信，中医可以作为哮喘的预防性患和再加的步骤，其治果也优于即便如此欧美的方面研究者。由于其研究者步骤的大胆和重要性，该科学论文还被亚太地区享有盛名药学药理学政府部门“千名科学家”附送。（生物谷 Bioon.com）

doi:10.1016/j.pain.2011.04.006PMC:PMID:

Efficacy of acupuncture for migraine prophylaxis: A single-blinded, double-dummy, randomized controlled trial

Lin-Peng Wang,Xiao-Zhe Zhang,Jia Guo,Hui-Lin Liu,Yan Zhang,Cun-Zhi Liu,Jing-Hong Yi,Li-Ping Wang,Ji-Ping Zhao,Shan-Shan Li

Summary This multicenter, double-dummy trial suggested that acupuncture was more effective than flunarizine in decreasing days of migraine attacks. Abstract Insufficient clinical trial data were ailable to prove the efficacy of acupuncture for migraine prophylaxis. A multicenter, double-dummy, single-blinded, randomized controlled clinical trial was conducted at the outpatient departments of acupuncture at 5 hospitals in China to evaluate the effectiveness of acupuncture. A total of 140 patients with migraine without aura were recruited and assigned randomly to 2 different groups: the acupuncture group treated with verum acupuncture plus placebo and the control group treated with sham acupuncture plus flunarizine. Treated by acupuncture 3 times per week and drugs every night, patients from both groups were evaluated at week 0 (baseline), week 4, and week 16. The primary outcome was measured by the proportion of responders (defined as the proportion of patients with a reduction of migraine days by at least 50%). The secondary outcome measures included the number of migraine days, visual ogue scale (VAS, 0 to 10cm) for pain, as well as the physical and mental component summary scores of the 36-item short-form health survey (SF-36). The patients in the acupuncture group had better responder rates and fewer migraine days compared with the control group (P.05). The results suggested that acupuncture was more effective than flunarizine in decreasing days of migraine attacks, whereas no significantly differences were found between acupuncture and flunarizine in reduction of pain intensity and improvement of the quality of life.